Company intelligence / Profile preview

Nordic Biomarker

Umeå, Västerbottens län, Swedennordicbiomarker.com ↗

Ownership: Private
Employees: ~67
Development stage: Commercial

Overview

Nordic Biomarker manufactures CE-marked and IVDR-certified diagnostic reagents for coagulation analysis, including D-dimer assays. Their products are used globally for routine and specialty laboratory diagnostics. The company has transitioned its portfolio to comply with the latest EU In Vitro Diagnostic Medical Devices Regulation. No therapeutics or clinical trial results; focus on commercialized diagnostic products.

Therapeutic areas: Hematology
Modalities: Protein (diagnostic reagents)Immunologic assay reagentsChromogenic assay reagentsLatex reagent (for D-dimer and coagulation analysis)
Industry: Protein Biomarker Diagnostics

Partnerships

Umeå University collaboration on research challenges/hackathons

Beyond the preview

Go deeper on Nordic Biomarker.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nordic Biomarker.

Explore the full profile